Growth Opportunities in the Western European IVD Industry, Forecast to 2021

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets. The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants. This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.
Published: 23 Jun 2017

Growth Opportunities in the Western European IVD Industry, Forecast to 2021

Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.

The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.

This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.

Key Questions This Study Will Answer

  • Which segments of the market are growing, how long will they continue to grow, and at what rate?
  • What are the key factors driving market growth?
  • What are the rising disruptive technologies and strategies that push IVD to better market opportunities and progress?
  • What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
  • Which new technologies hold the potential for IVD application?
  • Are the products/services offered currently meeting customers’ needs, or is there a need for additional development?

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..